Klaria Pharma Holding AB Logo

Klaria Pharma Holding AB

Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.

KLAR | ST

Overview

Corporate Details

ISIN(s):
SE0007280326
LEI:
529900YLMSNHNP7HOD11
Country:
Sweden
Address:
Virdings Allé 2, 754 50 UPPSALA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Klaria Pharma Holding AB is a pharmaceutical company that develops novel drug products based on its patented, proprietary alginate-based oral transmucosal film technology. This platform delivers active pharmaceutical ingredients directly into the bloodstream by adhering to the inside of the cheek, providing a non-invasive alternative to treatments currently available only as injections or nasal sprays. The company's strategy focuses on addressing significant patient needs where its technology offers clear advantages, such as improved convenience, safety, and efficacy. Klaria's development pipeline includes treatments for migraine (Sumatriptan), severe allergic reactions (Epinephrine), and organ transplant rejection (Sirolimus). The company also operates a subsidiary, Cannabis Delivery Sciences, which applies the film technology to cannabinoid-based products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Klaria Pharma Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Klaria Pharma Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Kamada Ltd. Logo
Develops specialty plasma-derived therapeutics for rare and serious conditions.
Israel KMDA
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea 217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea 038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea 256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Logo
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
Japan 4547

Talk to a Data Expert

Have a question? We'll get back to you promptly.